215 related articles for article (PubMed ID: 31597594)
1. Dual function of miR-1248 links interferon induction and calcium signaling defects in Sjögren's syndrome.
Jang SI; Tandon M; Teos L; Zheng C; Warner BM; Alevizos I
EBioMedicine; 2019 Oct; 48():526-538. PubMed ID: 31597594
[TBL] [Abstract][Full Text] [Related]
2. The Transcriptome of Paired Major and Minor Salivary Gland Tissue in Patients With Primary Sjögren's Syndrome.
Verstappen GM; Gao L; Pringle S; Haacke EA; van der Vegt B; Liefers SC; Patel V; Hu Y; Mukherjee S; Carman J; Menard LC; Spijkervet FKL; Vissink A; Bootsma H; Kroese FGM
Front Immunol; 2021; 12():681941. PubMed ID: 34295332
[TBL] [Abstract][Full Text] [Related]
3. Type I Interferon Dependent hsa-miR-145-5p Downregulation Modulates MUC1 and TLR4 Overexpression in Salivary Glands From Sjögren's Syndrome Patients.
Jara D; Carvajal P; Castro I; Barrera MJ; Aguilera S; González S; Molina C; Hermoso M; González MJ
Front Immunol; 2021; 12():685837. PubMed ID: 34149728
[TBL] [Abstract][Full Text] [Related]
4. Synaptotagmin-1 overexpression under inflammatory conditions affects secretion in salivary glands from Sjögren's syndrome patients.
Cortés J; Hidalgo J; Aguilera S; Castro I; Brito M; Urra H; Pérez P; Barrera MJ; Carvajal P; Urzúa U; González S; Molina C; Bahamondes V; Hermoso M; González MJ
J Autoimmun; 2019 Feb; 97():88-99. PubMed ID: 30391023
[TBL] [Abstract][Full Text] [Related]
5. Targeting the Ca(2+) Sensor STIM1 by Exosomal Transfer of Ebv-miR-BART13-3p is Associated with Sjögren's Syndrome.
Gallo A; Jang SI; Ong HL; Perez P; Tandon M; Ambudkar I; Illei G; Alevizos I
EBioMedicine; 2016 Aug; 10():216-26. PubMed ID: 27381477
[TBL] [Abstract][Full Text] [Related]
6. T cell exosome-derived miR-142-3p impairs glandular cell function in Sjögren's syndrome.
Cortes-Troncoso J; Jang SI; Perez P; Hidalgo J; Ikeuchi T; Greenwell-Wild T; Warner BM; Moutsopoulos NM; Alevizos I
JCI Insight; 2020 May; 5(9):. PubMed ID: 32376798
[TBL] [Abstract][Full Text] [Related]
7. Innate immune signaling induces interleukin-7 production from salivary gland cells and accelerates the development of primary Sjögren's syndrome in a mouse model.
Jin JO; Shinohara Y; Yu Q
PLoS One; 2013; 8(10):e77605. PubMed ID: 24147035
[TBL] [Abstract][Full Text] [Related]
8. hsa-miR-424-5p and hsa-miR-513c-3p dysregulation mediated by IFN-γ is associated with salivary gland dysfunction in Sjögren's syndrome patients.
Carvajal P; Aguilera S; Jara D; Indo S; Barrera MJ; González S; Molina C; Heathcote B; Hermoso M; Castro I; González MJ
J Autoimmun; 2023 Jul; 138():103037. PubMed ID: 37229808
[TBL] [Abstract][Full Text] [Related]
9. Short-chain fatty acid butyrate induces IL-10-producing B cells by regulating circadian-clock-related genes to ameliorate Sjögren's syndrome.
Kim DS; Woo JS; Min HK; Choi JW; Moon JH; Park MJ; Kwok SK; Park SH; Cho ML
J Autoimmun; 2021 May; 119():102611. PubMed ID: 33631650
[TBL] [Abstract][Full Text] [Related]
10. NKp30 Receptor Upregulation in Salivary Glands of Sjögren's Syndrome Characterizes Ectopic Lymphoid Structures and Is Restricted by Rituximab Treatment.
Pontarini E; Sciacca E; Grigoriadou S; Rivellese F; Lucchesi D; Fossati-Jimack L; Coleby R; Chowdhury F; Calcaterra F; Tappuni A; Lewis MJ; Fabris M; Quartuccio L; Bella SD; Bowman S; Pitzalis C; Mavilio D; De Vita S; Bombardieri M
Front Immunol; 2021; 12():706737. PubMed ID: 34594326
[TBL] [Abstract][Full Text] [Related]
11. Decreased circulating CXCR3 + CCR9+T helper cells are associated with elevated levels of their ligands CXCL10 and CCL25 in the salivary gland of patients with Sjögren's syndrome to facilitate their concerted migration.
Blokland SLM; Kislat A; Homey B; Smithson GM; Kruize AA; Radstake TRDJ; van Roon JAG
Scand J Immunol; 2020 Mar; 91(3):e12852. PubMed ID: 31733111
[TBL] [Abstract][Full Text] [Related]
12. Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis.
Nezos A; Gravani F; Tassidou A; Kapsogeorgou EK; Voulgarelis M; Koutsilieris M; Crow MK; Mavragani CP
J Autoimmun; 2015 Sep; 63():47-58. PubMed ID: 26183766
[TBL] [Abstract][Full Text] [Related]
13. Increased mTORC1 activation in salivary gland B cells and T cells from patients with Sjögren's syndrome: mTOR inhibition as a novel therapeutic strategy to halt immunopathology?
Blokland SLM; Hillen MR; Wichers CGK; Zimmermann M; Kruize AA; Radstake TRDJ; Broen JCA; van Roon JAG
RMD Open; 2019; 5(1):e000701. PubMed ID: 30713717
[No Abstract] [Full Text] [Related]
14. Adipose tissue is prominent in salivary glands of Sjögren's syndrome patients and appears to influence the microenvironment in these organs.
Skarstein K; Aqrawi LA; Øijordsbakken G; Jonsson R; Jensen JL
Autoimmunity; 2016 Aug; 49(5):338-46. PubMed ID: 27206986
[TBL] [Abstract][Full Text] [Related]
15. CD40 on salivary gland epithelial cells: high constitutive expression by cultured cells from Sjögren's syndrome patients indicating their intrinsic activation.
Dimitriou ID; Kapsogeorgou EK; Moutsopoulos HM; Manoussakis MN
Clin Exp Immunol; 2002 Feb; 127(2):386-92. PubMed ID: 11876766
[TBL] [Abstract][Full Text] [Related]
16. Plasmacytoid dendritic cells promote the pathogenesis of Sjögren's syndrome.
Zhou J; Zhang X; Yu Q
Biochim Biophys Acta Mol Basis Dis; 2022 Feb; 1868(2):166302. PubMed ID: 34780913
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-7/Interferon Axis Drives T Cell and Salivary Gland Epithelial Cell Interactions in Sjögren's Syndrome.
Rivière E; Pascaud J; Virone A; Dupré A; Ly B; Paoletti A; Seror R; Tchitchek N; Mingueneau M; Smith N; Duffy D; Cassard L; Chaput N; Pengam S; Gauttier V; Poirier N; Mariette X; Nocturne G
Arthritis Rheumatol; 2021 Apr; 73(4):631-640. PubMed ID: 33058491
[TBL] [Abstract][Full Text] [Related]
18. Salivary gland secretome: a novel tool towards molecular stratification of patients with primary Sjögren's syndrome and non-autoimmune sicca.
Blokland SLM; Hillen MR; van Vliet-Moret FM; Bikker A; de Jager W; Pandit A; Kruize AA; Radstake TRDJ; van Roon JAG
RMD Open; 2019; 5(1):e000772. PubMed ID: 30713719
[TBL] [Abstract][Full Text] [Related]
19. Expression of type III interferons (IFNλs) and their receptor in Sjögren's syndrome.
Apostolou E; Kapsogeorgou EK; Konsta OD; Giotakis I; Saridaki MI; Andreakos E; Tzioufas AG
Clin Exp Immunol; 2016 Dec; 186(3):304-312. PubMed ID: 27613139
[TBL] [Abstract][Full Text] [Related]
20. Involvement of Aquaporins in the Pathogenesis, Diagnosis and Treatment of Sjögren's Syndrome.
Soyfoo MS; Chivasso C; Perret J; Delporte C
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
